Cell Types that Produce GM-CSF
|
Cellular and Molecular Signals Involved
|
Th17 cells |
IL-23-mediated expression of RORγt [48,57]. |
ThGM
|
IL-7-mediated activation of STAT5 [54]; IL-23R and IL-1R signaling [55]. |
CD8+ T cells |
IL-23 induces but IFN-β suppresses GM-CSF production [58,59]. |
B cells |
B-cell receptor, CD40, and IL-4-mediated STAT5/6 activation [60]. |
Dendritic cells |
CCL17/CCL22-mediated expression of GM-CSF via CCR4 [56]. |
CNS endothelial cells |
Monocyte-produced, IL-1β-mediated expression of GM-CSF [61]. |
Cell Types that Respond to GM-CSF
|
Cell Type-Specific Biological Function of GM-CSF during EAE
|
Monocytes |
Stimulates CNS migration; induces the production of proinflammatory cytokines and neurotoxic mediators; promotes cell differentiation [62,63,64,65]. |
Dendritic cells |
Induces the production of IL-23 that promotes EAE [56]. |
CD103+ dendritic cells |
Induces cell accumulation in the skin and peripheral lymph nodes that can then present antigen to pathogenetic CD4+ T cells [66]. |
Neutrophils |
Promotes cell accumulation in the brain that causes atypical EAE [67]. |
Microglia |
Induces activation and promotes onset of EAE [43,68]. |
Astrocytes |
Promotes the upregulation of proinflammatory gene expression [69]. |